Physician profile
Peter Kluge
NPI 1861613523
$4,994.65
in general payments reported to CMS, 2019-2025
6 companies · $32.93 in 2025
The $32.93 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,696 · 2020: $74.05 · 2021: $129 · 2022: $206 · 2023: $1,732 · 2024: $124 · 2025: $32.93.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,256 · Food and Beverage: $633.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,255.59 |
| Food and Beverage | $633.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $2,654.95 | 2019-2023 | Sapien 3 Ultra Resilia |
| Abbott Laboratories | $2,125.14 | 2019-2023 | Fortify Assura, Gallant, Assurity |
| Medtronic, INC. | $109.91 | 2021-2024 | Symplicity G3 |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $57.10 | 2024 | Lifevest |
| Boston Scientific Corporation | $32.93 | 2025 | Enroute Transcarotid Neuroprotection System |
| Biotronik INC. | $14.62 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Peter Kluge listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.